Stroke Prevention in Atrial Fibrillation: Our Current Failures and Required Research

Keyphrases

• Clinical High Risk 100%
• Ischemic Stroke 100%
• Atrial Fibrillation 100%
• Left Atrial Appendage 100%
• Stroke Prevention in Atrial Fibrillation 100%
• Stroke Prevention 100%
• Older Adults 50%
• Non-valvular Atrial Fibrillation 50%
• Systemic Embolism 50%
• Middle-aged 50%
• Clinically Significant 50%
• Patient Demographics 50%
• Failure Rate 50%
• Non-pharmacological Methods 50%
• Oral Anticoagulants 50%
• Consensus Statement 50%
• Ischemic Events 50%
• FDA-approved Drugs 50%
• Risk-benefit 50%
• Anticoagulant Use 50%
• Embolic Event 50%
• Randomized Phase III Trial 50%
• Hemorrhagic Risk 50%
• Factor Xa Inhibitors 50%
• Direct Thrombin Inhibitors 50%
• Ischemic Risk 50%
• Rhythm Disorders 50%
• Inhibitor Factor 50%
• Strict Compliance 50%
• Factor XIa Inhibitor 50%

Medicine and Dentistry

• Apoplexy 100%
• Atrial Fibrillation 100%
• Antithrombotic 50%
• Brain Ischemia 50%
• Middle Age 25%
• Randomized Controlled Trial 25%
• Patient Population 25%
• Bleeding 25%
• Rhythm 25%
• Blood Clotting Factor 10a Inhibitor 25%
• Direct Thrombin Inhibitor 25%
• Blood Clotting Factor 11a Inhibitor 25%
• Diseases 25%